NCT03765203View on ClinicalTrials.gov

Utility of a Novel Dd-cfDNA Test to Detect Injury in Renal Post-Transplant Patients

NACompletedINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

November 5, 2018

Primary Completion Date

January 7, 2019

Study Completion Date

January 7, 2019

Conditions
Transplant;Failure,Kidney
Interventions
DIAGNOSTIC_TEST

Natera KidneyScan

Online educational materials on Natera Kidneyscan (dd-cfDNA) and sample test results for simulated patients

OTHER

Clinical Performance and Value Vignettes

Online renal allograft simulated patients

Trial Locations (1)

94109

QURE Healthcare, San Francisco

Sponsors

Collaborators (1)

Natera, Inc.
All Listed Sponsors
collaborator

Natera, Inc.

INDUSTRY

lead

Qure Healthcare, LLC

INDUSTRY

NCT03765203 - Utility of a Novel Dd-cfDNA Test to Detect Injury in Renal Post-Transplant Patients | Biotech Hunter | Biotech Hunter